Trial intelligence / Profile preview

High Dose Steroids in Children with Stroke and Unilateral Focal Arteriopathy

2021-005571-39Phase 3Active

Sponsor
Inselspital
Start
Jan 2022
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of methylprednisolone and prednisolone in ischemic stroke and focal cerebral arteriopathy (FCA) (2 arms), sponsored by Inselspital. Started Jan 2022; status: active.

02

Drugs

methylprednisoloneprednisolone
03

Conditions

ischemic strokefocal cerebral arteriopathy (FCA)

Beyond the preview

Go deeper on 2021-005571-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-005571-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call